Literature DB >> 9544631

Cutaneous melanoma metastatic to the vitreous cavity.

K Gündüz1, J A Shields, C L Shields, R C Eagle.   

Abstract

OBJECTIVE: The authors report their experience with cutaneous melanoma metastatic to the vitreous and elaborate on the features of this entity.
DESIGN: The study design was a retrospective review. PARTICIPANTS: Three patients with four affected eyes from cutaneous melanoma metastatic to the vitreous participated. INTERVENTION: All three patients were white men, and their mean age was 58 years. The previously excised cutaneous melanomas were all Clark level IV. The mean interval from diagnosis of the primary cutaneous melanoma to vitreous metastasis was 25 months. Ocular findings included clumps of cells arranged in sheets or linear strands on the vitreous framework. The vitreous cells were nonpigmented in two cases and pigmented in one case. Neovascular glaucoma was found in all three cases. After the diagnosis of vitreous melanoma was made by cytopathologic examination, external beam irradiation (5000 cGy) was given in all patients. MAIN OUTCOME MEASURES: Local tumor control and survival were measured.
RESULTS: At a mean follow-up of 14 months from diagnosis of vitreous melanoma, tumor control was achieved in only one of the four affected eyes. One eye was enucleated because of painful neovascular glaucoma, and the other two eyes had progressive vitreous disease. After a mean follow-up of 14 months (from ocular diagnosis), all three patients had died.
CONCLUSION: Cutaneous melanoma metastatic to the vitreous can present with nonpigmented or pigmented cells. Neovascular glaucoma frequently is found. External beam radiation therapy often is unsuccessful in local tumor control, and systemic prognosis is poor.

Entities:  

Mesh:

Year:  1998        PMID: 9544631     DOI: 10.1016/S0161-6420(98)94011-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

Review 1.  Neovascular glaucoma.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2007-08-08       Impact factor: 21.198

2.  Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading.

Authors:  Jasmine H Francis; Duncan Berry; David H Abramson; Christopher A Barker; Chris Bergstrom; Hakan Demirci; Michael Engelbert; Hans Grossniklaus; Baker Hubbard; Codrin E Iacob; Korey Jaben; Madhavi Kurli; Michael A Postow; Jedd D Wolchok; Ivana K Kim; Jill R Wells
Journal:  Ophthalmology       Date:  2019-09-24       Impact factor: 12.079

3.  Posterior capsule opacity as initial manifestation of metastatic cutaneous melanoma.

Authors:  Jonathan D Solomon; Carol L Shields; Jerry A Shields; Ralph C Eagle
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-09       Impact factor: 3.117

4.  [Unusual masquerade of an ocular carcinoma metastasis].

Authors:  M I Wunderlich; E J Nissen; M Schargus; H B Dick; M Pohl; S E Coupland; V Kakkassery
Journal:  Ophthalmologe       Date:  2016-08       Impact factor: 1.059

5.  Features of Cutaneous Malignant Melanoma Metastatic to the Retina and Vitreous.

Authors:  Mark P Breazzano; Ann E Barker-Griffith
Journal:  Ocul Oncol Pathol       Date:  2015-09-22

Review 6.  Metastatic tumours to the eye. Review of metastasis to the iris, ciliary body, choroid, retina, optic disc, vitreous, and/or lens capsule.

Authors:  Carol L Shields; Nicholas E Kalafatis; Maikel Gad; Mrittika Sen; Andrea Laiton; Ana Maria Velasco Silva; Kushal Agrawal; Sara E Lally; Jerry A Shields
Journal:  Eye (Lond)       Date:  2022-03-19       Impact factor: 3.775

7.  Occurrence of ocular melanoma thirteen years after skin melanoma: two separate primaries or metastatic disease? A case solved with NRAS and CDKN2A (INK4A-ARF) mutational analysis.

Authors:  Heidi V N Küsters-Vandevelde; Jan E E Keunen; Pieter Wesseling; Marian A J Verdijk; Marjolijn J L Ligtenberg; Willeke A M Blokx
Journal:  Virchows Arch       Date:  2008-03       Impact factor: 4.064

8.  [Vitreous metastasis of malignant cutaneous melanoma during treatment with ipilimumab].

Authors:  N Kellermann; M Maier; N Feucht
Journal:  Ophthalmologe       Date:  2017-02       Impact factor: 1.059

Review 9.  [Intraocular metastases].

Authors:  D Westerwick; F Driever; C H D Le Guin; K W Schmid; K A Metz
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

10.  Mechanisms of Optic Nerve Invasion in Primary Choroidal Melanoma.

Authors:  Eszter Szalai; Jill R Wells; Hans E Grossniklaus
Journal:  Ocul Oncol Pathol       Date:  2017-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.